NCT04212806 (Val-SpA) is a clinical trial in Axial Spondyloarthritis, sponsored by University Hospital, Grenoble.

Who is sponsoring NCT04212806?

NCT04212806 is sponsored by University Hospital, Grenoble.

What condition does NCT04212806 study?

NCT04212806 studies Axial Spondyloarthritis, Ankylosing Spondylitis.

Is NCT04212806 still recruiting?

NCT04212806 is currently completed. Last updated 23 November 2022.

Last reviewed 2022-11-23 · How we verify

NCT04212806: Val-SpA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

French Validation of Axial Spondyloarthritis Questionnaires (Val-SpA)

Completed Last updated 23 November 2022

What this trial tests

trial in Axial Spondyloarthritis in 5 participants. Completed in 31 December 2020.

Timeline

27 January 2020

Primary endpoint
7 September 2020

31 December 2020

Quick facts

Lead sponsor	University Hospital, Grenoble
Status	Completed
Study type	OBSERVATIONAL
Enrollment	5
Start date	27 January 2020
Primary completion	7 September 2020
Estimated completion	31 December 2020
Sites	2 locations across France

Conditions studied

Axial Spondyloarthritis — all drugs for Axial Spondyloarthritis →
Ankylosing Spondylitis — all drugs for Ankylosing Spondylitis →

Sponsor

University Hospital, Grenoble

Who can join

18 and older, any sex, with Axial Spondyloarthritis or Ankylosing Spondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to do a French linguistic validation of three questionnaires used in axial Spondyloarthritis (BASFI, BAS-G, Dougados Functional Index). In order to validate the questionnaires, a prospective, qualitative, observational and monocentric study will be conducted.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Translation and French Linguistic Validation of the Bath Ankylosing Spondylitis Functional Index and the Bath Ankylosing Spondylitis Global Score in Patients with Axial Spondyloarthritis.
Soulard J, Vaillant J, Baillet A, Vuillerme N. · · 2023 · cited 1× · PMID 36043728 · DOI 10.2174/1573397118666220829124234

Verify or expand the search:

Other recruiting trials for Axial Spondyloarthritis

Currently open trials in the same condition.

NCT07087912 — Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases · Phase 4 · recruiting
NCT07290036 — A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adu · Phase 1 · recruiting
NCT06888193 — A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® · Phase 1 · recruiting
NCT07414823 — Walking Football for Axial Spondyloarthritis · NA · active not recruiting
NCT07148414 — A Study of SPY072 in Rheumatic Disease · Phase 2 · recruiting

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04212806 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 23 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04212806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing